However, researchers should be aware that even under euglycemic conditions, SGLT2 inhibitors induce glucosuria that interferes with accurate ERPF measurement as a result of glycosylation of PAH in stored urine samples. This evidence concerns the gene SLC5A2 and Glycosuria.